172 related articles for article (PubMed ID: 21381109)
1. 19F-lanthanide complexes with increased sensitivity for 19F-MRI: optimization of the MR acquisition.
Chalmers KH; Kenwright AM; Parker D; Blamire AM
Magn Reson Med; 2011 Oct; 66(4):931-6. PubMed ID: 21381109
[TBL] [Abstract][Full Text] [Related]
2. Fe- and Ln-DOTAm-F12 Are Effective Paramagnetic Fluorine Contrast Agents for MRI in Water and Blood.
Srivastava K; Weitz EA; Peterson KL; Marjańska M; Pierre VC
Inorg Chem; 2017 Feb; 56(3):1546-1557. PubMed ID: 28094930
[TBL] [Abstract][Full Text] [Related]
3. Strategies to enhance signal intensity with paramagnetic fluorine-labelled lanthanide complexes as probes for 19F magnetic resonance.
Chalmers KH; Botta M; Parker D
Dalton Trans; 2011 Jan; 40(4):904-13. PubMed ID: 21127807
[TBL] [Abstract][Full Text] [Related]
4. Aryl-phosphonate lanthanide complexes and their fluorinated derivatives: investigation of their unusual relaxometric behavior and potential application as dual frequency 1H/19F MRI probes.
Placidi MP; Botta M; Kálmán FK; Hagberg GE; Baranyai Z; Krenzer A; Rogerson AK; Tóth I; Logothetis NK; Angelovski G
Chemistry; 2013 Aug; 19(35):11644-60. PubMed ID: 23868470
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight paramagnetic
Herynek V; Martinisková M; Bobrova Y; Gálisová A; Kotek J; Hermann P; Koucký F; Jirák D; Hájek M
MAGMA; 2019 Feb; 32(1):115-122. PubMed ID: 30498883
[TBL] [Abstract][Full Text] [Related]
6. Design principles and theory of paramagnetic fluorine-labelled lanthanide complexes as probes for (19)F magnetic resonance: a proof-of-concept study.
Chalmers KH; De Luca E; Hogg NH; Kenwright AM; Kuprov I; Parker D; Botta M; Wilson JI; Blamire AM
Chemistry; 2010 Jan; 16(1):134-48. PubMed ID: 19957317
[TBL] [Abstract][Full Text] [Related]
7. Characterization of perfluorocarbon relaxation times and their influence on the optimization of fluorine-19 MRI at 3 tesla.
Colotti R; Bastiaansen JAM; Wilson A; Flögel U; Gonzales C; Schwitter J; Stuber M; van Heeswijk RB
Magn Reson Med; 2017 Jun; 77(6):2263-2271. PubMed ID: 27385530
[TBL] [Abstract][Full Text] [Related]
8. 19F NMR based pH probes: lanthanide(III) complexes with pH-sensitive chemical shifts.
Kenwright AM; Kuprov I; De Luca E; Parker D; Pandya SU; Senanayake PK; Smith DG
Chem Commun (Camb); 2008 Jun; (22):2514-6. PubMed ID: 18506228
[TBL] [Abstract][Full Text] [Related]
9. Ligation driven (19)F relaxation enhancement in self-assembled Ln(III) complexes.
Davies GL; Brown A; Blackburn O; Tropiano M; Faulkner S; Beer PD; Davis JJ
Chem Commun (Camb); 2015 Feb; 51(14):2918-20. PubMed ID: 25586055
[TBL] [Abstract][Full Text] [Related]
10. Isoquinoline-based lanthanide complexes: bright NIR optical probes and efficient MRI agents.
Caillé F; Bonnet CS; Buron F; Villette S; Helm L; Petoud S; Suzenet F; Tóth E
Inorg Chem; 2012 Feb; 51(4):2522-32. PubMed ID: 22233349
[TBL] [Abstract][Full Text] [Related]
11. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
[TBL] [Abstract][Full Text] [Related]
12. CEST-MRI studies of cells loaded with lanthanide shift reagents.
Ferrauto G; Di Gregorio E; Delli Castelli D; Aime S
Magn Reson Med; 2018 Oct; 80(4):1626-1637. PubMed ID: 29516549
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive MR thermometry using paramagnetic lanthanide complexes of 1,4,7,10-tetraazacyclodoecane-alpha,alpha',alpha'',alpha'''-tetramethyl-1,4,7,10-tetraacetic acid (DOTMA4-).
Hekmatyar SK; Hopewell P; Pakin SK; Babsky A; Bansal N
Magn Reson Med; 2005 Feb; 53(2):294-303. PubMed ID: 15678553
[TBL] [Abstract][Full Text] [Related]
14. Optimization of rapid acquisition with relaxation enhancement (RARE) pulse sequence parameters for ¹⁹F-MRI studies.
Mastropietro A; De Bernardi E; Breschi GL; Zucca I; Cametti M; Soffientini CD; de Curtis M; Terraneo G; Metrangolo P; Spreafico R; Resnati G; Baselli G
J Magn Reson Imaging; 2014 Jul; 40(1):162-70. PubMed ID: 25050436
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a lanthanide complex encapsulated with MRI contrast agents into liposomes for biosensor imaging of redundant deviation in shifts (BIRDS).
Maritim S; Huang Y; Coman D; Hyder F
J Biol Inorg Chem; 2014 Dec; 19(8):1385-98. PubMed ID: 25304046
[TBL] [Abstract][Full Text] [Related]
16. Fluorine nuclear magnetic resonance: calibration and system optimization.
Nelson TR; Newman FD; Schiffer LM; Reith JD; Cameron SL
Magn Reson Imaging; 1985; 3(3):267-73. PubMed ID: 4079674
[TBL] [Abstract][Full Text] [Related]
17. Development of Ln(III) Derivatives as
Kaster MA; Caldwell MA; Meade TJ
Inorg Chem; 2024 May; 63(21):9877-9887. PubMed ID: 38748735
[No Abstract] [Full Text] [Related]
18. Exploiting the Fluxionality of Lanthanide Complexes in the Design of Paramagnetic Fluorine Probes.
Wilharm RK; Ramakrishnam Raju MV; Hoefler JC; Platas-Iglesias C; Pierre VC
Inorg Chem; 2022 Mar; 61(9):4130-4142. PubMed ID: 35196450
[TBL] [Abstract][Full Text] [Related]
19.
Xie D; Yu M; Kadakia RT; Que EL
Acc Chem Res; 2020 Jan; 53(1):2-10. PubMed ID: 31809009
[TBL] [Abstract][Full Text] [Related]
20. Clinical perspectives of hybrid proton-fluorine magnetic resonance imaging and spectroscopy.
Wolters M; Mohades SG; Hackeng TM; Post MJ; Kooi ME; Backes WH
Invest Radiol; 2013 May; 48(5):341-50. PubMed ID: 23211551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
